Crude Oil Moves Lower; Summit Therapeutics Shares Plummet

by

in

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling over 200 points on Tuesday.

The Dow traded down 0.18% to 38,557.86 while the NASDAQ fell 1.30% to 15,570.84. The S&P 500 also fell, dropping, 0.73% to 4,969.26.

Check This Out: Top 4 Tech Stocks That May Crash This Month

 

Leading and Lagging Sectors

 

Consumer staples shares rose by 1.2% on Tuesday.

In trading on Tuesday, information technology shares fell by 1.8%.

 

Top Headline

 

The Conference Board’s Leading Economic Index fell 0.4% for January, versus market expectations for a 0.3% decline.

 

Equities Trading UP

 

Monopar Therapeutics Inc. (NASDAQ: MNPR) shares shot up 90% to $0.6472 after the company announced it received Human Research Ethics Committee clearance in Australia to commence a Phase 1 dosimetry trial of its novel radiopharmaceutical MNPR-101-Zr.

Shares of Biofrontera Inc. (NASDAQ: BFRI) got a boost, surging 68% to $1.25 after the company announced a private placement of …

Full story available on Benzinga.com